What is the treatment for Stevens-Johnson Syndrome (SJS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Stevens-Johnson Syndrome (SJS)

The most critical first step in treating Stevens-Johnson Syndrome is immediate discontinuation of any potential culprit drug, followed by prompt transfer to a specialized care center with experience managing SJS/TEN, preferably a burn unit or ICU for patients with >10% body surface area epidermal detachment. 1, 2

Initial Management

  • Immediately discontinue any potential culprit medication as the first and most critical intervention 1
  • Calculate SCORTEN within the first 24 hours of admission to predict mortality risk 3, 2
  • Transfer patients with >10% body surface area epidermal detachment to a specialized burn unit or ICU with experience treating SJS/TEN 3, 2
  • Place patient in a temperature-controlled room (25-28°C) on a pressure-relieving mattress with barrier nursing 3, 1

Supportive Care

Skin Management

  • Handle skin carefully to minimize shearing forces and prevent further epidermal detachment 3, 1
  • Apply bland emollients to support barrier function and reduce transcutaneous water loss 3, 1
  • Use appropriate non-adherent dressings (such as Mepitel™ or Telfa™) on denuded dermis to reduce fluid and protein loss, limit microbial colonization, and control pain 3, 1
  • Take regular swabs for bacterial and candidal culture from lesional skin, particularly sloughy areas 1, 2

Fluid Management

  • Carefully monitor fluid balance with regular assessment of vital signs and urine output 1, 2
  • Establish adequate intravenous fluid replacement while avoiding fluid overload that can lead to pulmonary, cutaneous, and intestinal edema 1, 2

Infection Prevention

  • Monitor for signs of systemic infection rather than using prophylactic antibiotics, which may increase skin colonization with resistant organisms 3, 1
  • Only institute antimicrobial therapy when clinical signs of infection are present 3, 1

Mucosal Management

Ocular Care

  • Arrange ophthalmology consultation within 24 hours of diagnosis for all patients 1, 2
  • Apply frequent lubrication with preservative-free artificial tears and lubricating ointments 1
  • Perform daily examination for symblepharon formation with lysis of adhesions by an ophthalmologist to prevent permanent scarring 1
  • Use topical antibiotics when corneal fluorescein staining or ulceration is present 1
  • Consider topical corticosteroid drops under ophthalmologist supervision to reduce ocular surface damage 1

Oral Care

  • Use anti-inflammatory oral rinses containing benzydamine hydrochloride every 3 hours, particularly before eating 1
  • Apply antiseptic oral rinses twice daily 1
  • Consider topical anesthetics such as viscous lidocaine 2% for severe oral discomfort 1
  • Monitor for and treat secondary infections with appropriate antifungals or antivirals if needed 1

Urogenital Care

  • Consider urinary catheterization when urogenital involvement causes dysuria or retention 1
  • Apply white soft paraffin ointment to urogenital skin and mucosae every 4 hours 1
  • Consider vaginal dilators or tampons wrapped in non-adherent dressings to prevent vaginal synechiae formation 1

Systemic Therapy Options

  • Systemic corticosteroids may be beneficial if started early (preferably within 72 hours), using moderate to high doses (prednisolone 1-2 mg/kg/day or equivalent) tapered rapidly within 7-10 days 3, 1, 4
  • Cyclosporine (3-5 mg/kg/day for 10-14 days) may be used either alone or in combination with corticosteroids 3, 4
  • Etanercept (TNF-alpha inhibitor) may reduce mortality compared to corticosteroids alone, though evidence is limited 5, 6
  • Intravenous immunoglobulin (IVIG) has been used but with uncertain benefit based on current evidence 5, 7

Multidisciplinary Approach

  • Coordinate care through a multidisciplinary team including dermatology, intensive care, ophthalmology, and specialist skincare nursing 3, 1
  • Consider additional input from respiratory medicine, gastroenterology, gynecology, urology, oral medicine, microbiology, pain team, dietetics, physiotherapy, and pharmacy as needed 3, 1

Common Pitfalls to Avoid

  • Delayed recognition and treatment significantly increases mortality risk 1, 2
  • Indiscriminate use of prophylactic antibiotics may increase skin colonization with resistant organisms 3, 1
  • Overaggressive fluid resuscitation can lead to pulmonary, cutaneous, and intestinal edema 1, 2
  • Failure to involve ophthalmology early can lead to permanent visual impairment 1, 2
  • Continued use of the culprit medication will worsen the condition and increase mortality 1, 2

References

Guideline

Treatment of Stevens-Johnson Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Emergency Treatment for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2022

Research

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Clinical reviews in allergy & immunology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.